Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 6
2005 2
2006 1
2007 2
2011 1
2012 6
2013 2
2014 1
2015 4
2016 2
2017 3
2018 1
2019 5
2020 3
2021 3
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Genetic characteristics of platinum-sensitive ovarian clear cell carcinoma.
Saito R, Kuroda T, Yoshida H, Sudo K, Saito M, Tanabe H, Takano H, Yamada K, Kiyokawa T, Yonemori K, Kato T, Okamoto A, Kohno T. Saito R, et al. Among authors: yamada k. Jpn J Clin Oncol. 2023 Aug 30;53(9):781-790. doi: 10.1093/jjco/hyad045. Jpn J Clin Oncol. 2023. PMID: 37248674
Clinical Features of Borderline Ovarian Seromucinous Tumor.
Nagayoshi Y, Yamada K, Kiyokawa T, Fukasawa N, Kuroda T, Noguchi D, Okamoto A. Nagayoshi Y, et al. Among authors: yamada k. Cancer Diagn Progn. 2023 May 3;3(3):360-364. doi: 10.21873/cdp.10224. eCollection 2023 May-Jun. Cancer Diagn Progn. 2023. PMID: 37168956 Free PMC article.
Vaginal Transmission of Cancer from Mothers with Cervical Cancer to Infants.
Arakawa A, Ichikawa H, Kubo T, Motoi N, Kumamoto T, Nakajima M, Yonemori K, Noguchi E, Sunami K, Shiraishi K, Kakishima H, Yoshida H, Hishiki T, Kawakubo N, Kuroda T, Kiyokawa T, Yamada K, Yanaihara N, Takahashi K, Okamoto A, Hirabayashi S, Hasegawa D, Manabe A, Ono K, Matsuoka M, Arai Y, Togashi Y, Shibata T, Nishikawa H, Aoki K, Yamamoto N, Kohno T, Ogawa C. Arakawa A, et al. Among authors: yamada k. N Engl J Med. 2021 Jan 7;384(1):42-50. doi: 10.1056/NEJMoa2030391. N Engl J Med. 2021. PMID: 33406329
Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601.
Ito K, Nakagawa M, Shimokawa M, Hori K, Tashima L, Goto M, Yanagida S, Suzuki J, Kaya R, Kawabata A, Yamada K, Park J, Nasu H, Nishio S, Kondo E, Kaneda M, Tsubamoto H, Arakawa A, Nagasawa T, Motohashi T. Ito K, et al. Among authors: yamada k. Anticancer Drugs. 2023 Aug 1;34(7):857-865. doi: 10.1097/CAD.0000000000001472. Epub 2022 Dec 5. Anticancer Drugs. 2023. PMID: 36729915 Clinical Trial.
43 results